News

Mission

The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Does Methylene Blue or Mitoquinone Improve Skeletal Aging?

Aging

April 3, 2024

PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 6, entitled, “Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.” continue reading »

Altered Brain Morphology and Functional Connectivity in Postmenopausal Women

Aging

April 1, 2024

PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 16, Issue 6, entitled, “Altered brain morphology and functional connectivity in postmenopausal women: automatic segmentation of whole-brain and thalamic subnuclei and resting-state fMRI.” continue reading »

Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer

Oncotarget

March 27, 2024

PRESS RELEASE: On March 19, 2024, a new research paper was published in Oncotarget, entitled, “Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer.” continue reading »

Chlorogenic Acid Prevents Ovariectomized-induced Bone Loss

News

March 26, 2024

PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 5, entitled, “Chlorogenic acid prevents ovariectomized-induced bone loss by facilitating osteoblast functions and suppressing osteoclast formation.” continue reading »

ABT199/Venetoclax Synergism With Thiotepa in Acute Myeloid Leukemia (AML) Cells

News

March 25, 2024

PRESS RELEASE: On March 14, 2024, a new research paper was published in Oncotarget, entitled, “ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells.” continue reading »

« Previous 1 … 28 29 30 31 32 … 102 Next »